A Systematic Review and Meta-Analysis: Volatile Organic Compound Analysis in the Detection of Hepatobiliary and Pancreatic Cancers
- PMID: 37190235
- PMCID: PMC10136496
- DOI: 10.3390/cancers15082308
A Systematic Review and Meta-Analysis: Volatile Organic Compound Analysis in the Detection of Hepatobiliary and Pancreatic Cancers
Abstract
Background: Hepatobiliary cancers are notoriously difficult to detect, frequently leading to diagnosis in later stages of disease when curative treatment is not an option. The currently used biomarkers such as AFP (alpha-fetoprotein) and CA19.9 lack sensitivity and specificity. Hence, there is an unmet need for an alternative biomarker.
Aim: To evaluate the diagnostic accuracy of volatile organic compounds (VOCs) for the detection of hepatobiliary and pancreatic cancers.
Methods: A systematic review of VOCs' use in the detection of hepatobiliary and pancreatic cancers was performed. A meta-analysis was performed using the software R. Heterogeneity was explored through meta-regression analysis.
Results: A total of 18 studies looking at 2296 patients were evaluated. Pooled sensitivity and specificity of VOCs for the detection of hepatobiliary and pancreatic cancer were 0.79 (95% CI, 0.72-0.85) and 0.81 (97.5% CI, 0.76-0.85), respectively. The area under the curve was 0.86. Meta-regression analysis showed that the sample media used contributed to heterogeneity. Bile-based VOCs showed the highest precision values, although urine and breath are preferred for their feasibility.
Conclusions: Volatile organic compounds have the potential to be used as an adjunct tool to aid in the early diagnosis of hepatobiliary cancers.
Keywords: gallbladder cancer; hepatocellular cancer; pancreatic cancer; volatile organic compounds.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Diagnostic Ability of Volatile Organic Compounds in Digestive Cancer: A Systematic Review With Meta-Analysis.Clin Med Insights Oncol. 2022 Jun 20;16:11795549221105027. doi: 10.1177/11795549221105027. eCollection 2022. Clin Med Insights Oncol. 2022. PMID: 35754925 Free PMC article.
-
Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.JAMA Oncol. 2019 Jan 1;5(1):e182815. doi: 10.1001/jamaoncol.2018.2815. Epub 2019 Jan 10. JAMA Oncol. 2019. PMID: 30128487 Free PMC article.
-
Volatile organic compounds analysis as promising biomarkers for Parkinson's disease diagnosis: A systematic review and meta-analysis.Clin Neurol Neurosurg. 2023 Dec;235:108022. doi: 10.1016/j.clineuro.2023.108022. Epub 2023 Oct 28. Clin Neurol Neurosurg. 2023. PMID: 37939618 Review.
-
Volatile Organic Compounds in Human Exhaled Breath to Diagnose Gastrointestinal Cancer: A Meta-Analysis.Front Oncol. 2021 Feb 26;11:606915. doi: 10.3389/fonc.2021.606915. eCollection 2021. Front Oncol. 2021. PMID: 33747921 Free PMC article.
-
Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.Cancer Biomark. 2017 Dec 12;21(1):29-39. doi: 10.3233/CBM-170177. Cancer Biomark. 2017. PMID: 29060925 Review.
Cited by
-
Advancements in breath-based diagnostics for pancreatic cancer: Current insights and future perspectives.World J Gastrointest Oncol. 2024 Jun 15;16(6):2300-2303. doi: 10.4251/wjgo.v16.i6.2300. World J Gastrointest Oncol. 2024. PMID: 38994133 Free PMC article.
-
The Detection of Colorectal Cancer through Machine Learning-Based Breath Sensor Analysis.Diagnostics (Basel). 2023 Oct 31;13(21):3355. doi: 10.3390/diagnostics13213355. Diagnostics (Basel). 2023. PMID: 37958251 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources